Arlington Partners LLC Repligen Corp Transaction History

Arlington Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 26, 2023	BUY	$154.26 - $198.1 $3,856 - $4,952	25 New	25 $4,000
Q2 2022 Jul 25, 2022	SELL	$140.68 - $188.02 $23,915 - $31,963	-170 Closed	0 $0
Q1 2022 Apr 14, 2022	SELL	$161.19 - $257.96 $45,939 - $73,518	-285 Reduced 62.64%	170 $32,000
Q4 2021 Jan 18, 2022	SELL	$247.59 - $304.47 $25,254 - $31,055	-102 Reduced 18.31%	455 $121,000
Q3 2021 Oct 15, 2021	BUY	$194.77 - $324.21 $108,486 - $180,584	557 New	557 $161,000

487

54.4M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $6.92B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Arlington Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Arlington Partners LLC with notifications on news.